3744 results for «2024»
3744 results
Apply now for a chance of granting towards participation at EuroPCR 2024
Highlights from EAPCI-PCR Fellows Course 2024
New in 2024: complimentary childcare for your little ones!
New in 2024: complimentary childcare for your little ones!
Digital coverage of PCR London Valves 2024
#GulfPCR: Digital coverage of GulfPCR-GIM 2024
PCR Innovators Day 2024: a new Director joins the team!
EuroPCR 2024 – Andreas Grüntzig Ethica Award winners of EuroPCR 2024: Ottavio Alfieri and Frederick St Goar
15 May 2024
Paris, France, 15 May 2024. During each edition of EuroPCR, the Andreas Grüntzig Ethica Award, which recognises outstanding achievements and contributions to the cardiovascular field, is presented. On 15th May, at the Palais des Congrès, Porte Maillot in Paris, a special ceremony was held to bestow...
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
TAVI innovations: late-breaking trials from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.
You’ll dive into the CANNULATE TAVR EXTENDED...
PCR London Valves 2024 Welcome Ceremony: a global milestone in heart valve care
24 Nov 2024 – From PCR London Valves 2024
Discover the incredible journey of PCR London Valves, from its origins in 2009 to becoming the premier global event in heart valve care. What started as a small gathering focused on aortic valve therapies has grown into a landmark event, bringing together nearly 4,000 professionals annually...
2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases
09 Sep 2024
The 2024 ESC Guidelines for aortic diseases, merged with peripheral arterial disease guidelines, update prior guidance and emphasize atherosclerotic conditions. In this article, Antoine Sauguet summarizes the content related to peripheral arterial diseases.
Author
Compare TAVI - Top Late Breaking Trial at PCR London Valves 2024
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase and Christian Terkelsen review the one-year results of the Compare TAVI randomized study, which set a benchmark for evaluating the performance and safety of new transcatheter heart valves (THVs) compared to best-in-practice THVs. The findings revealed that the Myval THV series was non-inferior...
TRISCEND II: Top Late Breaking Trial at PCR London Valves 2024
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase and Raj Makkar share key insights from the TRISCEND II study. This innovative research addresses a crucial question: can transcatheter tricuspid valve replacement improve symptoms, quality of life, and clinical outcomes in patients? Listen as Makkar details the enrolled population and the study's...
What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?
15 May 2024 – From EuroPCR 2024
Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...
PCR London Valves – The best of
ESC Practice Guidelines 2024: chronic coronary syndromes
30 Aug 2024
Julia Grapsa provides her take on the Chronic Coronary Syndromes (CCS) Guidelines which were presented by Felicita Andreotti and Christiaan Vrints at ESC Congress 2024 in London.
Author
Focus on Imaging - PCR London Valves 2024
Victoria Delgado and Nina Wunderlich delve into the imaging highlights from PCR London Valves 2024, emphasizing the critical role of advanced imaging for structural interventions. They spotlight the importance of emerging technologies in achieving precise, well-dosed procedures. A standout feature is the Imaging Learning Centre, offering...
Focus on Innovation - PCR London Valves 2024
Azeem Latib and Jose Calle Gordo reflect on the PCR London Valves 2024 programme, which showcased groundbreaking advancements in valve technology. Highlights included sessions on transforming ideas into market-ready devices, intimate small-group discussions fostering meaningful exchange, and a hands-on innovation session to explore new devices. The...
